All Things Considered for April 28, 2022 Hear the All Things Considered program for April 28, 2022

All Things Considered

Moderna says its vaccine appears to be about 51 percent effective for children ages 6 months to less than 2 years, and 37 percent effective for those ages 2 to less than 6 years. Ole Spata/dpa picture alliance via Getty Images hide caption

toggle caption
Ole Spata/dpa picture alliance via Getty Images

Shots - Health News

Moderna asks FDA to authorize first COVID-19 vaccine for very young children

The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.

Moderna says its vaccine appears to be about 51 percent effective for children ages 6 months to less than 2 years, and 37 percent effective for those ages 2 to less than 6 years. Ole Spata/dpa picture alliance via Getty Images hide caption

toggle caption
Ole Spata/dpa picture alliance via Getty Images

Moderna asks FDA to authorize first COVID-19 vaccine for very young children

  • Download
  • <iframe src="https://www.npr.org/player/embed/1095052893/1095365261" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Searching for a song you heard between stories? We've retired music buttons on these pages. Learn more here.

All Things Considered